Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
If the FDA dont approve the IND then SP tanks back to the low 2's maybe even high 1s. People are buying this because they believe Hemogenyx are about to go clinical. There is no debate or argument to be had, if they dont get approval then Hemo will have to raise cash to see them though to the re-re-submission.
HOWEVER
If Vlad having agreed the plan with the FDA to lift the Clinical Hold, knowing EXACTLY what they require, has submitted a response that does not deliver what he has promised to deliver? Then the SP would deserve to tank!
But at this point we have Penn, the expert advisors, we have Prevail, ALL will have had insight to the clinical hold response. Hemogenyx identified the one issue raised by the FDA BEFORE the FDA notified them, Hemogenyx came up with a robust plan to lift the hold that went further than the single issue raised by the FDA, the FDA APPROVED that plan and Hemogenyx have stated that they have done what was asked. On average 95% of IND applications go though without a hitch first time, we had a hitch, I have zero concerns that the FDA wont lift the CH.
If your asking who is selling? Who cares! Whoever it is is selling on news and 100% would sell on IND approval, let them sell now, on a patent lol! Cya traders 😆
:-D
Lol, pumpkin knows it's 30 calendar days 😆 and she has been very very quiet..... me thinks someone sold at 3p and never got a chance to get back in. 🙃
If people really want to trade and will only buy cheaper? Lol, good luck, I was happy to pay 3.4p today,more than I have paid in a very very long time. But let's be clear, hemo is massively undervalued.
Nice 500k buy just printed...
Side note, Remember HEMO-CAR-T is the SMALLEST part of the Hemogenyx Pipeline, its also the EASIEST to value and closest to clinical trials and most likely to be sold off. So with this in mind, I asked how much HEMO-CAR-T is worth:
Valuation Ranges:
Early Phase 1: $20 million - $75 million: AML being a high-unmet need disease with limited treatment options can justify a higher starting point than the general range.
Mid-Phase 1: $30 million - $150 million: Initial safety and efficacy data, especially against a difficult-to-treat cancer like AML, can significantly impact value.
Late Phase 1: $75 million - $300 million: Positive safety and efficacy signals showing promise for AML patients could lead to substantial investor interest.
Thats a 20-300m Valuation for HEMO-CAR-T ONLY in Phase 1... For a company with mCap of 35mil....
I love a good blue weekend, upbeat, people have a few days to find us and do some research, the shorts get VERY nervous and you can tell who is out/short because there will be some panic ridden posts on here. And Monday morning is a fantastic time for RNS.
Be different if we were waiting for drilling results on a mining stock and it was 50:50 or something. But we are waiting on the FDA to respond to a response to clinical hold where the FDA already did a full review, already said they found only one issue, already agreed with Hemogenyx a plan to lift the clinical hold and Hemogenyx have already confirmed they did all they were asked for and have done the required testing. Waiting with Hemogenyx is 90% excitement, 8% frustration and about 2% nervousness. Just aslong as we dont get "the RNS" at like 4.01pm on a friday like we have in the past!!!!
Looking forward to it :-) Ideal scenario (And from what I hear very possible)
FDA let Hemo know tomorrow but Vlad does not RNS until 7am monday morning
FOMO Friday and we hit 4p
Shorts stay open over the weekend.
That would leave me requiring new boxers monday morning.
Period of consolidation followed by a bit of a shake to rinse out the weak hands and any stops then move it up. If it let the shorts out without losing their shirts then I am not impressed, IF however an RNS were now to drop we would be launching from a more stable base so all good :-)
14,000 i was robbed. thats me for another month!
Ok... Now I am upset... £3 tu buy online with IG, but just rang up, only looking 500 quid because offer not being filled and "That will cost you £50 for a phone dealing charge!!!" £50 quid????
Normally end of month I have a few k to stick in, only have 500 this month, just came though. NT :P
Limit order placed to buy at 3.4 14500 shares, wish it had come in earlier! Darn HR department....
Pure speculation on my behalf aswell, but I looked at the terms and conditions of the grant and yes it looked perfect for CBR HOWEVER there was a few requirements which IMO put Vlad off, he would have had to report and be very open to a representative about what the company are doing, who they are speaking too, results etc. So personally I think he just did not want that level of transparency that would be required, CBR could be the next Microsoft and Vlad does not want to give away the secret sauce recipe just yet.
Why oh why do I not actually practice what I preach? This is clockwork what happened the last few times. Like I mean the timings, the short percentage the volumes, the percentage walk down on zero volume. Well, maybe next time :P
Calling it now - We close blue.
Lol, reference to "Shake"
After 5 years of this share you get very used to seeing the MMs shake the SP around like this, can predict what happens next but dont want to be accused of ramping :P
As has been pointed out the short position on IG is back to 7%, it had dropped to 0% and when that last happened the SP went up to 3.4-3.8. Since then the absolute highest the bid has been was 3.4 and at that price only a few 100k shares were sold. Why should this make us cheerful you ask? Because when you open a short you "Sell" and IG will always give you a worse spread than advertised to make their profit, so even at 3.4 that sell would be 3.38 HOWEVER that window was tiny so our 7% is most likely 3.18 or 3.28 at best, and with the ask at 3.5342? Do the math! Basically they aint making profit as it stands AND a short is just a delayed buy so when they decide to close it is going to push the SP up. The FDA have like 1 week left give or take, most people dont expect them to take the 30 days and the general consensus is that the hold will be lifted.
Or maybe our shorter is actually holding in the hope that the FDA dont lift the hold? THAT is high risk gambling! Its possible... everything is possible... But considering what we have seen in multiple shares lately on a good RNS?... Balls of steel.
Pid just remember that most of us are already fully invested, as much as we may be convinced about whats coming we dont have bottomless pockets. As HH has highlighted the SP has improved and volume is up, but visibility here is still extremely low. There is no coverage on twitter or anywhere else and whilst we have attracted some new shareholders many of those are easily swayed to chase unicorns in some oil or mining stock that has just paid a few k to pump their SP so they can get away another placing. Take comfort in the fact that Hemogenyx is silent and waiting for the FDA, no hype or pump, no pump and dump crew screaming Hemo all over Twitter, just silent waiting for the FDA and a CEO who is determined to raise a middle finger to those who doubted him.
Anyway, Friday is usually a Hemo day, Monday/Tuesday is the day for big updates so check back tomorrow for FOMO Friday.
Or premium bonds, not a bad return right now and a bit of excitement aswell!
Andy, let me rephrase that for you. You put money in a preclinical, you put more money in a preclinical, even more in a preclinical and now years later your holding a preclinical that is waiting for a decision from the FDA on being allowed to start clinical trials which is due any time in the next week :-)
Moor:
https://www.lse.co.uk/rns/HEMO/single-cbr-can-treat-multiple-viruses-btbliw44cz9mry8.html
To the best of my knowledge this is the one with US Gov involvement, every update from Hemogenyx has alluded to the fact that CBR is progressing but being delayed by lack of resources, be that time, staff, resources or funds. 2 Months ago:
"The funds will also enable the Company, in view of recently announced successes, to provide modest additional resources to the development of its CBR platform."
Multiple interviews and zoom meetings over the past year its been made clear, Priority 1 - GET CLINICAL
Getting Clinical will unlock staff, resources and most importantly enable a significant cash injection.
I dont think Vlad would just not release RNS's because he is waiting for CH to be lifted but I believe 100% that going clinical will trigger progress in CDX and CBR.
I am hopeful Vlad will do some sort of update on CDX and CBR when the CH is lifted, either way, a very exciting few months ahead.